Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy - PubMed (original) (raw)
. 2007 Jan 1;67(1):196-203.
doi: 10.1016/j.ijrobp.2006.08.010. Epub 2006 Oct 27.
Affiliations
- PMID: 17071013
- DOI: 10.1016/j.ijrobp.2006.08.010
Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy
Diclehan Unsal Kilic et al. Int J Radiat Oncol Biol Phys. 2007.
Abstract
Purpose: To analyze whether the expression of matrix metalloproteinases (MMPs) and their tissue inhibitors are associated with tumor response to preoperative chemoradiotherapy in rectal cancer patients.
Methods and materials: Forty-four patients who had undergone preoperative chemoradiotherapy were evaluated retrospectively. Treatment consisted of pelvic radiotherapy and two cycles of 5-fluorouracil plus leucovorin. Surgery was performed 6-8 weeks later. MMP-2, MMP-9, and tissue inhibitors of metalloproteinase-1 and -2 expression was analyzed by immunohistochemistry of the preradiation biopsy and surgical specimens. The intensity and extent of staining were evaluated separately, and a final score was calculated by multiplying the two scores. The primary endpoint was the correlation of expression with tumor response, with the secondary endpoint the effect of chemoradiotherapy on the expression.
Results: Preoperative treatment resulted in downstaging in 20 patients (45%) and no clinical response in 24 (55%). The pathologic tumor response was complete in 11 patients (25%), partial in 23 (52%), and none in 10 (23%). Positive MMP-9 staining was observed in 20 tumors (45%) and was associated with the clinical nodal stage (p = 0.035) and the pathologic and clinical response (p < 0.0001). The staining status of the other markers was associated with neither stage nor response. The overall pathologic response rate was 25% in MMP-9-positive patients vs. 52% in MMP-9-negative patients (p = 0.001). None of the 11 patients with pathologic complete remission was MMP-9 positive.
Conclusions: Matrix metalloproteinase-9 expression correlated with a poor tumor response to preoperative chemoradiotherapy in rectal carcinoma patients.
Similar articles
- Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A. Unsal D, et al. Am J Clin Oncol. 2008 Feb;31(1):55-63. doi: 10.1097/COC.0b013e318068b4e2. Am J Clin Oncol. 2008. PMID: 18376229 - Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy.
Kim JS, Kim JM, Li S, Yoon WH, Song KS, Kim KH, Yeo SG, Nam JS, Cho MJ. Kim JS, et al. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):195-200. doi: 10.1016/j.ijrobp.2006.04.026. Epub 2006 Jul 12. Int J Radiat Oncol Biol Phys. 2006. PMID: 16839708 - Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Chan AK, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77. doi: 10.1016/j.ijrobp.2004.06.206. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708244 Clinical Trial. - Induction therapy for rectal carcinoma.
Busse PM, Ng A, Recht A. Busse PM, et al. Semin Surg Oncol. 1998 Sep;15(2):120-5. doi: 10.1002/(sici)1098-2388(199809)15:2<120::aid-ssu9>3.0.co;2-1. Semin Surg Oncol. 1998. PMID: 9730418 Review.
Cited by
- Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.
Li M, Xiao Q, Venkatachalam N, Hofheinz RD, Veldwijk MR, Herskind C, Ebert MP, Zhan T. Li M, et al. Ther Adv Med Oncol. 2022 Feb 21;14:17588359221077972. doi: 10.1177/17588359221077972. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35222695 Free PMC article. Review. - Superoxide Dismutase Mimic, MnTE-2-PyP Enhances Rectal Anastomotic Strength in Rats after Preoperative Chemoradiotherapy.
Yang Y, Wang Q, Luo J, Jiang Y, Zhou R, Tong S, Wang Z, Tong Q. Yang Y, et al. Oxid Med Cell Longev. 2020 Apr 13;2020:3509859. doi: 10.1155/2020/3509859. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32351671 Free PMC article. - Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.
Del Gobbo A, Ferrero S. Del Gobbo A, et al. Gastroenterol Res Pract. 2017;2017:2808235. doi: 10.1155/2017/2808235. Epub 2017 Feb 23. Gastroenterol Res Pract. 2017. PMID: 28326100 Free PMC article. Review. - Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer.
Perez I, Blanco L, Sanz B, Errarte P, Ariz U, Beitia M, Fernández A, Loizate A, Candenas ML, Pinto FM, Gil J, López JI, Larrinaga G. Perez I, et al. Int J Med Sci. 2015 Jun 2;12(6):458-67. doi: 10.7150/ijms.11808. eCollection 2015. Int J Med Sci. 2015. PMID: 26078706 Free PMC article. - Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.
Larrinaga G, Perez I, Blanco L, Sanz B, Errarte P, Beitia M, Etxezarraga MC, Loizate A, Gil J, Irazusta J, López JI. Larrinaga G, et al. Int J Med Sci. 2014 Jan 10;11(2):199-208. doi: 10.7150/ijms.7178. eCollection 2014. Int J Med Sci. 2014. PMID: 24465166 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous